المصدر: A Phase 3 Study of Dinutuximab Added to Intensive Multimodal Therapy for Children With Newly Diagnosed High-Risk Neuroblastoma

Other URLs: https://grants.nih.gov/policy/sharing.htm

المصدر: Utility of Gallium-68-DOTA-Octreotate PET/CT in the Characterization of Pediatric Neuroendocrine Tumors

المؤلفون: National Cancer Institute (NCI)

المصدر: A COG Pilot Study of Intensive Induction Chemotherapy and 131I-MIBG Followed by Myeloablative Busulfan/Melphalan (Bu/Mel) for Newly Diagnosed High-Risk Neuroblastoma
Weiss BD, Yanik G, Naranjo A, Zhang FF, Fitzgerald W, Shulkin BL, Parisi MT, Russell H, Grupp S, Pater L, Mattei P, Mosse Y, Lai HA, Jarzembowski JA, Shimada H, Villablanca JG, Giller R, Bagatell R, Park JR, Matthay KK. A safety and feasibility trial of 131 I-MIBG in newly diagnosed high-risk neuroblastoma: A Children's Oncology Group study. Pediatr Blood Cancer. 2021 Oct;68(10):e29117. doi: 10.1002/pbc.29117. Epub 2021 May 24.

المؤلفون: National Cancer Institute (NCI)

المصدر: A Phase 3 Study of 131I-Metaiodobenzylguanidine (131I-MIBG) or ALK Inhibitor Therapy Added to Intensive Therapy for Children With Newly Diagnosed High-Risk Neuroblastoma (NBL)
Weiss BD, Yanik G, Naranjo A, Zhang FF, Fitzgerald W, Shulkin BL, Parisi MT, Russell H, Grupp S, Pater L, Mattei P, Mosse Y, Lai HA, Jarzembowski JA, Shimada H, Villablanca JG, Giller R, Bagatell R, Park JR, Matthay KK. A safety and feasibility trial of 131 I-MIBG in newly diagnosed high-risk neuroblastoma: A Children's Oncology Group study. Pediatr Blood Cancer. 2021 Oct;68(10):e29117. doi: 10.1002/pbc.29117. Epub 2021 May 24.

المؤلفون: National Cancer Institute (NCI)

المصدر: Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients With Non-High-Risk Neuroblastoma

المؤلفون: National Cancer Institute (NCI)

المصدر: A Pilot Study of Dinutuximab, Sargramostim (GM-CSF), and Isotretinoin in Combination With Irinotecan and Temozolomide in the Post-Consolidation Setting for High-Risk Neuroblastoma

المصدر: A Pilot Induction Regimen Incorporating Chimeric 14.18 Antibody (ch14.18, Dinutuximab) (NSC# 764038) and Sargramostim (GM-CSF) for the Treatment of Newly Diagnosed High-Risk Neuroblastoma

Other URLs: https://grants.nih.gov/policy/sharing.htm

المؤلفون: National Cancer Institute (NCI)

المصدر: Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma

المؤلفون: Novartis Pharmaceuticals

المصدر: Molecularly-Driven Doublet Therapy for All Children With Refractory or Recurrent CNS Malignant Neoplasms and Young Adults With Refractory or Recurrent SHH Medulloblastoma

المؤلفون: University Medical Center, Kazakhstan

المصدر: Abdominal Neuroblastoma Laparoscopic Surgery Risk Factors Stratification

المؤلفون: The Evan Foundation, Ben Towne Center for Childhood Cancer Research

المساهمون: Colleen Annesley, Medical Director, Seattle Children's Therapeutics

المصدر: A Phase 1 Feasibility and Safety Study of Cellular Immunotherapy for Recurrent/Refractory Neuroblastoma Using Autologous T-cells Lentivirally Transduced to Express CD171-specific Chimeric Antigen Receptors

المصدر: SIOPEN BIOPORTAL, An International Registry Linked to a Virtual Biobank for Patients With Peripheral Neuroblastic Tumours

المؤلفون: National Cancer Institute (NCI)

المصدر: Neuroblastoma Biology Studies

المؤلفون: Arsenij Ustjanzew, Annekathrin Silvia Nedwed, Roger Sandhoff, Jörg Faber, Federico Marini, Claudia Paret

المصدر: Cancer & Metabolism, Vol 12, Iss 1, Pp 1-24 (2024)

مصطلحات موضوعية: Neuroblastoma, Ganglioneuroma, Ganglioneuroblastoma, Ganglioside, GD2, Glycosphingolipids, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2049-3002

URL الوصول: https://doaj.org/article/6c5814a3e6e648e095480b746037ea8d

المصدر: Introduction of Induction Chemoimmunotherapy Regimen for the Treatment of Pediatric Patients With Stage 4 High-risk Neuroblastoma and Ganglioneuroblastoma Older 18 Months

المصدر: A Phase 1/2 Study of AZD1775 (MK-1775) in Combination With Oral Irinotecan in Children, Adolescents, and Young Adults With Relapsed or Refractory Solid Tumors

المؤلفون: United Therapeutics

المصدر: A Phase II Randomized Trial of Irinotecan/Temozolomide With Temsirolimus (NSC# 683864) or Chimeric 14.18 Antibody (Ch14.18) (NSC# 764038) in Children With Refractory, Relapsed or Progressive Neuroblastoma
Mody R, Yu AL, Naranjo A, Zhang FF, London WB, Shulkin BL, Parisi MT, Servaes SE, Diccianni MB, Hank JA, Felder M, Birstler J, Sondel PM, Asgharzadeh S, Glade-Bender J, Katzenstein H, Maris JM, Park JR, Bagatell R. Irinotecan, Temozolomide, and Dinutuximab With GM-CSF in Children With Refractory or Relapsed Neuroblastoma: A Report From the Children's Oncology Group. J Clin Oncol. 2020 Jul 1;38(19):2160-2169. doi: 10.1200/JCO.20.00203. Epub 2020 Apr 28.
Mody R, Naranjo A, Van Ryn C, Yu AL, London WB, Shulkin BL, Parisi MT, Servaes SE, Diccianni MB, Sondel PM, Bender JG, Maris JM, Park JR, Bagatell R. Irinotecan-temozolomide with temsirolimus or dinutuximab in children with refractory or relapsed neuroblastoma (COG ANBL1221): an open-label, randomised, phase 2 trial. Lancet Oncol. 2017 Jul;18(7):946-957. doi: 10.1016/S1470-2045(17)30355-8. Epub 2017 May 23.

المؤلفون: Weiyu Li, Zhaoxing Ou, Zhanghai Wu, Liujun Li, Feile Ye, Xin Wen, Dalin Ye

المصدر: Heliyon, Vol 10, Iss 9, Pp e30891- (2024)

مصطلحات موضوعية: Ganglioneuroblastoma, Neuroblastoma, Prognosis, Nomogram, Risk factor, Science (General), Q1-390, Social sciences (General), H1-99

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2405844024069226; https://doaj.org/toc/2405-8440

URL الوصول: https://doaj.org/article/e76dc6d491704cf6b87d91578e86ac99

المؤلفون: Paulina Skrzypkowska, Michał Kunc, Wojciech Biernat

المصدر: Contemporary Oncology, Vol 27, Iss 2, Pp 118-121 (2023)

مصطلحات موضوعية: immunohistochemistry, melanoma, metastasis, ganglioneuroblastoma, Medicine

وصف الملف: electronic resource

Relation: https://www.termedia.pl/Great-mimicker-a-case-of-occult-melanoma-displaying-ganglioneuroblastic-differentiation,3,51343,1,1.html; https://doaj.org/toc/1428-2526; https://doaj.org/toc/1897-4309

URL الوصول: https://doaj.org/article/857630f0f607440c978ab0e409376eb6

المؤلفون: María José Andrade López, Isabella Garavis, Andrea Casanova, Diana Sarmiento, Lizeth Castro

المصدر: Revista Chilena de Anestesia, Vol 52, Iss 6, Pp 626-628 (2023)

مصطلحات موضوعية: ganglioneuroblastoma, pediatría, Medicine, Anesthesiology, RD78.3-87.3

وصف الملف: electronic resource

Relation: https://revistachilenadeanestesia.cl/PII/revchilanestv52n6-12.pdf; https://doaj.org/toc/0716-4076; https://doaj.org/toc/0719-6792

URL الوصول: https://doaj.org/article/89f1fccc31664cdd89725755256533df